By Derek Major ( October 25, 2017, 3:52 PM EDT) -- Allergan has asked a California federal judge not to toss its suit alleging Imprimis Pharmaceuticals illegally manufactures and sells unapproved new drugs under a drug compounding loophole in FDA regulations, saying it has shown that it complies with the Federal Food, Drug and Cosmetics Act and state regulations....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.